What's It Like to Work at Eyebot?

Key Insight for Candidates

• Mission & Purpose: The company frames its purpose around expanding access to vision care through quick, doctor‑reviewed prescriptions delivered via kiosks, creating clear patient‑impact orientation. Retail pilots and public materials present a mission‑first narrative grounded in real‑world use.
• Market Position & Stability: A $6M seed (June 2024) and $20M Series A (August 2025) alongside pilots in Walmart and Sam’s Club optical centers signal traction and reduce near‑term financing risk compared with pre‑seed. Visibility with well‑known investors and trade coverage suggests rising category recognition.
• Autonomy: A small, sub‑50 team with in‑office Boston roles and cross‑functional scopes points to high ownership and broad responsibility. Day‑to‑day work blends hardware, software, and clinical‑ops tasks with rapid field iteration in retail environments.

• Job Insecurity: In early 2026, the American Optometric Association urged FDA/FTC attention to Eyebot’s kiosks, adding policy and compliance risk that could affect operations, deployments, and roles. State patient‑safety alerts and ongoing regulator engagement create uncertainty around timelines and market access.
• Product Weaknesses: Go‑to‑market proof points are still developing, with execution dependent on kiosk reliability, doctor‑review workflows, and sustainable retail economics that may be uneven at this stage. Reports of pilot‑stage pricing differences and evolving partner models indicate the product and commercialization approach are still being hardened.
• Change Fatigue: Early‑stage realities such as role fluidity, evolving processes, and office‑centric rhythms require frequent adaptation. Field ops, travel, and cross‑team coordination in retail deployments can introduce continual shifts in priorities and practices.